Skip to main content
Erschienen in: Pediatric Surgery International 4/2006

01.04.2006 | Original Article

Evaluation of bone mineral density after ileocystoplasty in children with and without myelomeningocele

verfasst von: Ugur Boylu, Kaya Horasanli, Orhan Tanriverdi, Muammer Kendirci, Eyup Gumus, Cengiz Miroglu

Erschienen in: Pediatric Surgery International | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

We evaluated the bone mineral density (BMD) after ileal augmentation cystoplasty in a group of children with and without myelomeningocele. Between 1996 and 2003, eight patients with neurogenic bladder and seven patients with non-neurogenic bladder underwent augmentation ileocystoplasty. Preoperative and postoperative serum creatinine and electrolytes were measured. All patients underwent clinical evaluation, supine height measurement, blood gas analysis, and BMD measurement using a dual energy X-ray absorptiometry (DEXA) postoperatively. BMD was measured at L1–L4 and femoral neck, and compared to age- and sex-matched population. Follow-up time was calculated from the day of surgery to the day of DEXA performance. A total of eight boys and seven girls with the mean age of 10.2±4.1 years were evaluated with respect to BMD measurement. Mean age was 9.8 years in neurogenic group and 10.5 in non-neurogenic group. Mean follow-up was 728 and 616 days in neurogenic and non-neurogenic groups, respectively. There were no significant differences between ages, follow-up times, preoperative and postoperative creatinine levels, pH and bicarbonate values, and supine heights. Mean BMD at L1–L4 was 55.7% in neurogenic group and 83.8% in non-neurogenic group. There was a statistically significant difference between the two groups (P=0.02). Mean BMD at femoral neck was 72% in neurogenic group and 86.2% in non-neurogenic group. The difference was also statistically significant (P=0.028). After augmentation ileocystoplasty, the BMD in early postoperative period of patients with myelomeningocele is lower than the patients with non-neurogenic neurogenic bladder, which have the same clinical characteristics except the neurologic pathology. In the light of our findings and the reported literature data as well, we may claim that BMD decrease after augmentation ileocystoplasty depends more on the underlying neurologic pathology and its locomotor consequences rather than the enterocystoplasty itself.
Literatur
1.
2.
Zurück zum Zitat Goldwasser B, Webster GD (1986) Augmentation and substitution enterocystoplasty. J Urol 135:215–224PubMed Goldwasser B, Webster GD (1986) Augmentation and substitution enterocystoplasty. J Urol 135:215–224PubMed
3.
Zurück zum Zitat Mitchell ME, Piser JA (1987) Intestinocystoplasty and total bladder replacement in children and young adults: followup in 129 cases. J Urol 138:579–584PubMed Mitchell ME, Piser JA (1987) Intestinocystoplasty and total bladder replacement in children and young adults: followup in 129 cases. J Urol 138:579–584PubMed
4.
Zurück zum Zitat Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA (1998) Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 81:569–573PubMed Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA (1998) Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 81:569–573PubMed
5.
Zurück zum Zitat Mills RD, Studer UE (1999) Metabolic consequences of continent urinary diversion. J Urol 161:1057–1066CrossRefPubMed Mills RD, Studer UE (1999) Metabolic consequences of continent urinary diversion. J Urol 161:1057–1066CrossRefPubMed
6.
Zurück zum Zitat Shekarriz B, Upadhyay J, Demirbilek S, Barthold JS, Gonzalez R (2000) Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology 55:123–128CrossRefPubMed Shekarriz B, Upadhyay J, Demirbilek S, Barthold JS, Gonzalez R (2000) Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology 55:123–128CrossRefPubMed
7.
Zurück zum Zitat Kawakita M, Arai Y, Shigeno C, Terai A, Okada Y, Takeuchi H, Konishi J, Yoshida O (1996) Bone demineralization following urinary intestinal diversion assessed by urinary pyridinium cross-links and dual energy x-ray absorptiometry. J Urol 156:355–359CrossRefPubMed Kawakita M, Arai Y, Shigeno C, Terai A, Okada Y, Takeuchi H, Konishi J, Yoshida O (1996) Bone demineralization following urinary intestinal diversion assessed by urinary pyridinium cross-links and dual energy x-ray absorptiometry. J Urol 156:355–359CrossRefPubMed
8.
Zurück zum Zitat Stein R, Fisch M, Andreas J, Bockisch A, Hohenfellner R, Thuroff JW (1998) Whole-body potassium and bone mineral density up to 30 years after urinary diversion. Br J Urol 82:798–803PubMed Stein R, Fisch M, Andreas J, Bockisch A, Hohenfellner R, Thuroff JW (1998) Whole-body potassium and bone mineral density up to 30 years after urinary diversion. Br J Urol 82:798–803PubMed
9.
Zurück zum Zitat Feng AH, Kaar S, Elder JS (2002) Influence of enterocystoplasty on linear growth in children with exstrophy. J Urol 167:2552–2555; discussion 2555 Feng AH, Kaar S, Elder JS (2002) Influence of enterocystoplasty on linear growth in children with exstrophy. J Urol 167:2552–2555; discussion 2555
10.
Zurück zum Zitat Gros DA, Dodson JL, Lopatin UA, Gearhart JP, Silver RI, Docimo SG (2000) Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy. J Urol 164:917–920CrossRefPubMed Gros DA, Dodson JL, Lopatin UA, Gearhart JP, Silver RI, Docimo SG (2000) Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy. J Urol 164:917–920CrossRefPubMed
11.
Zurück zum Zitat Koch MO, McDougal WS, Hall MC, Hill DE, Braren HV, Donofrio MN (1992) Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. J Urol 147:1343–1347PubMed Koch MO, McDougal WS, Hall MC, Hill DE, Braren HV, Donofrio MN (1992) Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. J Urol 147:1343–1347PubMed
12.
Zurück zum Zitat Mundy AR, Nurse DE (1992) Calcium balance, growth and skeletal mineralisation in patients with cystoplasties. Br J Urol 69:257–259PubMed Mundy AR, Nurse DE (1992) Calcium balance, growth and skeletal mineralisation in patients with cystoplasties. Br J Urol 69:257–259PubMed
13.
Zurück zum Zitat Vajda P, Pinter AB, Harangi F, Farkas A, Vastyan AM, Oberritter Z (2003) Metabolic findings after colocystoplasty in children. Urology 62:542–546; discussion 546 Vajda P, Pinter AB, Harangi F, Farkas A, Vastyan AM, Oberritter Z (2003) Metabolic findings after colocystoplasty in children. Urology 62:542–546; discussion 546
14.
Zurück zum Zitat Wagstaff KE, Woodhouse CR, Duffy PG, Ransley PG (1992) Delayed linear growth in children with enterocystoplasties. Br J Urol 69:314–317PubMedCrossRef Wagstaff KE, Woodhouse CR, Duffy PG, Ransley PG (1992) Delayed linear growth in children with enterocystoplasties. Br J Urol 69:314–317PubMedCrossRef
15.
Zurück zum Zitat Quan A, Adams R, Ekmark E, Baum M (1998) Bone mineral density in children with myelomeningocele. Pediatrics 102:E34CrossRefPubMed Quan A, Adams R, Ekmark E, Baum M (1998) Bone mineral density in children with myelomeningocele. Pediatrics 102:E34CrossRefPubMed
16.
Zurück zum Zitat Tsukahara H, Sudo M, Umezaki M, Hiraoka M, Yamamoto K, Ishii Y, Haruki S (1992) Dual-energy X-ray absorptiometry in the lumbar spine, proximal femur and distal radius in children. Pediatr Radiol 22:560–562CrossRefPubMed Tsukahara H, Sudo M, Umezaki M, Hiraoka M, Yamamoto K, Ishii Y, Haruki S (1992) Dual-energy X-ray absorptiometry in the lumbar spine, proximal femur and distal radius in children. Pediatr Radiol 22:560–562CrossRefPubMed
17.
Zurück zum Zitat Neyzi O, Yalcindag A, Alp H (1973) Heights and weights of Turkish children. J Trop Pediatr Environ Child Health 19:5–13PubMed Neyzi O, Yalcindag A, Alp H (1973) Heights and weights of Turkish children. J Trop Pediatr Environ Child Health 19:5–13PubMed
18.
Zurück zum Zitat Abes M, Sarihan H, Madenci E (2003) Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation. J Pediatr Surg 38:230–232CrossRefPubMed Abes M, Sarihan H, Madenci E (2003) Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation. J Pediatr Surg 38:230–232CrossRefPubMed
19.
Zurück zum Zitat Hafez AT, McLorie G, Gilday D, Laudenberg B, Upadhyay J, Bagli D, Khoury AE (2003) Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol 170:1639–1641; discussion 1641–1642 Hafez AT, McLorie G, Gilday D, Laudenberg B, Upadhyay J, Bagli D, Khoury AE (2003) Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol 170:1639–1641; discussion 1641–1642
20.
Zurück zum Zitat Mingin GC, Nguyen HT, Mathias RS, Shepherd JA, Glidden D, Baskin LS (2002) Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics 110:1193–1198CrossRefPubMed Mingin GC, Nguyen HT, Mathias RS, Shepherd JA, Glidden D, Baskin LS (2002) Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics 110:1193–1198CrossRefPubMed
21.
Zurück zum Zitat Brkovic D, Seibel M, Juchem R, Linke J, Rohde D, Bauss F (2004) Effect of augmentation cystoplasty on bone metabolism in chronic uremic rats. J Urol 171:921–925CrossRefPubMed Brkovic D, Seibel M, Juchem R, Linke J, Rohde D, Bauss F (2004) Effect of augmentation cystoplasty on bone metabolism in chronic uremic rats. J Urol 171:921–925CrossRefPubMed
22.
Zurück zum Zitat Brkovic D, Seibel M, Kissling C, Dorsam J, Wiesel M, Staehler G, Bauss F (2000) Impaired bone metabolism following augmentation cystoplasties in growing rats. Eur Urol 38:766–773CrossRefPubMed Brkovic D, Seibel M, Kissling C, Dorsam J, Wiesel M, Staehler G, Bauss F (2000) Impaired bone metabolism following augmentation cystoplasties in growing rats. Eur Urol 38:766–773CrossRefPubMed
23.
Zurück zum Zitat Hochstetler JA, Flanigan MJ, Kreder KJ (1997) Impaired bone growth after ileal augmentation cystoplasty. J Urol 157:1873–1879CrossRefPubMed Hochstetler JA, Flanigan MJ, Kreder KJ (1997) Impaired bone growth after ileal augmentation cystoplasty. J Urol 157:1873–1879CrossRefPubMed
24.
Zurück zum Zitat Hasanoglu A, Tumer L, Ezgu FS (2004) Vertebra and femur neck bone mineral density values in healthy Turkish children. Turk J Pediatr 46:298–302PubMed Hasanoglu A, Tumer L, Ezgu FS (2004) Vertebra and femur neck bone mineral density values in healthy Turkish children. Turk J Pediatr 46:298–302PubMed
Metadaten
Titel
Evaluation of bone mineral density after ileocystoplasty in children with and without myelomeningocele
verfasst von
Ugur Boylu
Kaya Horasanli
Orhan Tanriverdi
Muammer Kendirci
Eyup Gumus
Cengiz Miroglu
Publikationsdatum
01.04.2006
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 4/2006
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-006-1660-5

Weitere Artikel der Ausgabe 4/2006

Pediatric Surgery International 4/2006 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.